We further investigated the correlation between CTLA-4 genotypes (+ 49A/G rs; 231,775 and CT60 A/G rs: 3,087,243) and the response to different lines of therapy; however, it was not statistically significant in our studied patients with ITP (Table 3). The gene discussed is CTLA4; the disease is autoimmune thrombocytopenic purpura.